止咳药市场规模 - 依药物类型（抗组织胺、抗生素、支气管扩张剂、减充血剂、祛痰药）、剂型（口服糖浆、片剂/丸剂、滴鼻剂、含片）、年龄组、配销通路与预测，2024年至2032年

在政府严格审批以确保安全标准的推动下，咳嗽药物市场规模预计从 2024 年到 2032 年复合年增长率将达到 5.6%。由于当局正在完善安全协议并审查新配方，因此监管机构正在评估其有效性和潜在副作用。

研究人员和製造商正在探索符合不断变化的监管要求的创新成分和配方。高度重视提高疗效，同时最大限度地降低风险，以确保咳嗽药物对公众使用仍然安全可靠，这将推动该行业的成长。例如，2023 年 12 月，印度药品监管总局 (DCGI) 发起了一项全国性行动，以确保止咳糖浆生产的全球品质标准。这项工作正在提高全国咳嗽药物的安全性和有效性标准。

整个市场分为药物类型、剂型、年龄层、配销通路和地区。

就药物类型而言，抗组织胺领域的咳嗽药市场预计从2024 年至2032 年将录得显着的复合年增长率。缓解过敏反应。人们也研究了它们在治疗各种过敏性疾病和症状方面的潜力。不断努力为受过敏影响的个人提供更有针对性和更有效的缓解，同时确保提高生活品质和更好地管理过敏反应，将有利于该细分市场的成长。

按配销通路，线上药局领域的止咳药产业预计将在 2024 年至 2032 年期间成长，因为它们能够透过提供便利的数位平台购买和交付医疗保健产品，从而改变药物取得管道。线上管道正在扩大服务范围，提供各种处方药和非处方药以及健康相关产品。他们还整合远距医疗服务，以改善用户介面并增强整体客户体验。

从地区来看，在广告和促销活动的增加以及生活方式的改变的推动下，亚太地区止咳药市场规模预计将在 2024 年至 2032 年间呈现强劲增长。随着该地区城市化和生活方式的不断发展，人们不断努力为城市居民量身定制行销策略。这种适应包括更广泛地利用数位平台，并製作有针对性的信息，以引起城市消费者的共鸣，寻求便捷有效的解决方案来管理该地区的呼吸健康。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 呼吸道疾病盛行率增加
    • 对非处方 (OTC) 产品的认知程度和需求提高
    • 老年人口激增
  • 产业陷阱与挑战
    • 与止咳药物相关的副作用
• 成长潜力分析
• 监管环境
• 管道分析
• 波特的分析
• PESTEL分析
• 未来市场趋势

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按药物类型，2021 - 2032 年

• 主要趋势
• 抗组织胺药
• 抗生素
• 支气管扩张剂
• 减充血剂
• 祛痰药

第 6 章：市场估计与预测：按剂型，2021 - 2032

• 主要趋势
• 口服糖浆
• 片剂/丸剂
• 滴鼻液
• 含片

第 7 章：市场估计与预测：按年龄划分，2021 - 2032

• 主要趋势
• 成人
• 儿科

第 8 章：市场估计与预测：按配销通路划分，2021 - 2032 年

• 主要趋势
• 零售药房
• 医院药房
• 网路药房
• 其他分销管道

第 9 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 10 章：公司简介

• AstraZeneca plc
• Bayer AG
• GSK plc
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• Prestige Consumer Healthcare
• Procter & Gamble
• Reckitt Benckiser Group plc
• Sun Pharmaceutical Industries Ltd

Cough Remedies Market size is projected to record 5.6% CAGR from 2024 to 2032, driven by stringent government approvals to ensure safety standards. Regulatory agencies are assessing their effectiveness and potential side effects due to rising scrutiny as authorities are refining safety protocols and reviewing new formulations.

Researchers and manufacturers are exploring innovative ingredients and formulations that comply with evolving regulatory requirements. The strong focus on enhancing efficacy while minimizing risks for ensuring that cough remedies remain safe and reliable for public use will drive the industry growth. For instance, in December 2023, the Drugs Controller General of India (DCGI) initiated a nationwide drive for ensuring global quality standards in cough syrup manufacturing. This effort is enhancing safety and efficacy standards for cough remedies across the country.

The overall market is segregated into medication type, dosage form, age group, distribution channel, and region.

In terms of medication type, the cough remedies market from the antihistamines segment is expected to record significant CAGR from 2024 to 2032. Antihistamines are widely utilized to alleviate allergic reactions by blocking histamine receptors in the body. They are also researched for their potential in treating various allergic conditions and symptoms. Rising efforts for providing more targeted and efficient relief for individuals affected by allergies while ensuring improved quality of life and better management of allergic reactions will favor the segment growth.

By distribution channel, the cough remedies industry from the online pharmacy segment is projected to rise from 2024 to 2032, driven by their ability of transforming access to medications by providing convenient digital platforms for purchasing and delivering healthcare products. Online channels are expanding their services to offer a wide range of prescription and over-the-counter medications, as well as health-related products. They are also integrating telemedicine services to improve user interface as well as enhance the overall customer experience.

Regionally, the Asia Pacific cough remedies market size is projected to exhibit robust growth between 2024 and 2032, fueled by the rise in advertising and promotional campaigns, along with changing lifestyles. As urbanization and lifestyles are evolving in the region, there are ongoing efforts to tailor marketing strategies to urban dwellers. This adaptation involves utilizing digital platforms more extensively and crafting targeted messages to resonate with urban consumers seeking convenient and effective solutions for managing respiratory health in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increase in prevalence of respiratory diseases
    • 3.2.1.2 Rise in awareness levels and demand for over-the-counter (OTC) products
    • 3.2.1.3 Surging geriatric population
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Side effects associated with cough medications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Pipeline analysis
• 3.6 Porter's analysis
• 3.7 PESTEL analysis
• 3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Medication Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Antihistamines
• 5.3 Antibiotics
• 5.4 Bronchodilators
• 5.5 Decongestants
• 5.6 Expectorants

Chapter 6 Market Estimates and Forecast, By Dosage Form, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Oral syrups
• 6.3 Tablets/Pills
• 6.4 Nasal drop
• 6.5 Lozenges

Chapter 7 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Adult
• 7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Retail pharmacy
• 8.3 Hospital pharmacy
• 8.4 Online pharmacy
• 8.5 Other distribution channels

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 AstraZeneca plc
• 10.2 Bayer AG
• 10.3 GSK plc
• 10.4 Johnson & Johnson
• 10.5 Novartis AG
• 10.6 Pfizer Inc.
• 10.7 Prestige Consumer Healthcare
• 10.8 Procter & Gamble
• 10.9 Reckitt Benckiser Group plc
• 10.10 Sun Pharmaceutical Industries Ltd